MSD Pharmaceuticals Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MSD Pharmaceuticals Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11509
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MSD Pharmaceuticals Pvt Ltd (MSD India), a subsidiary of Merck & Co Inc, is a healthcare products provider that offers prescription medicines, vaccines, biologic therapies, and animal health products. The company offers pipeline products such as medicines, tablets, capsules, solutions, and pharmaceutical products, among others. It also offers vaccines, women’s healthcare products, critical care products, chronic care products, and healthcare products. MSD India’s therapeutic areas include human health, metabolics, cardiovascular, vaccines, critical care, immunology, virology, oncology, women’s health, dermatology, respiratory, musculoskeletal, and primary care. The company operates in Australia, Austria, Belgium, Canada, Romania, Denmark, Egypt, Finland, France, Germany, Hungary, Japan, Malaysia, Taiwan, and Thailand. MSD India is headquartered in Mumbai, Maharashtra, India.

MSD Pharmaceuticals Pvt Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
MSD India Plans Co-Marketing Agreement For Diabetes Drugs 10
Licensing Agreements 11
Cipla Enters Into Licensing Agreement With MSD Pharma For Raltegravir 11
Asset Transactions 13
Piramal Enterprises Acquires Five OTC Brands from Organon India and MSD for USD14 Million 13
MSD Pharmaceuticals Pvt Ltd – Key Competitors 14
MSD Pharmaceuticals Pvt Ltd – Key Employees 15
MSD Pharmaceuticals Pvt Ltd – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Key Facts 2
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MSD Pharmaceuticals Pvt Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MSD India Plans Co-Marketing Agreement For Diabetes Drugs 10
Cipla Enters Into Licensing Agreement With MSD Pharma For Raltegravir 11
Piramal Enterprises Acquires Five OTC Brands from Organon India and MSD for USD14 Million 13
MSD Pharmaceuticals Pvt Ltd, Key Competitors 14
MSD Pharmaceuticals Pvt Ltd, Key Employees 15

List of Figures
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[MSD Pharmaceuticals Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Repsol SA Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Repsol SA Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Repsol SA (Repsol) is an integrated oil and gas company. It has presence across the entire value chain: exploration and production, transformation, development and marketing of energy. The company’s upstre …
  • BayWa AG:戦略・SWOT・企業財務分析
    BayWa AG - Strategy, SWOT and Corporate Finance Report Summary BayWa AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Evonik Industries AG (EVK):企業の財務・戦略的SWOT分析
    Evonik Industries AG (EVK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Hokkaido Electric Power Co Inc (9509):企業の財務・戦略的SWOT分析
    Hokkaido Electric Power Co Inc (9509) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Holland Board of Public Works:企業の戦略的SWOT分析
    Holland Board of Public Works - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Midea Group Co Ltd:企業の戦略・SWOT・財務分析
    Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Briggs & Stratton Corp (BGG):企業の財務・戦略的SWOT分析
    Briggs & Stratton Corp (BGG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • BowLeven plc (BLVN):企業の財務・戦略的SWOT分析
    Summary BowLeven plc (BowLeven) is an independent oil and gas exploration and production company. The company’s business activities include acquisition, exploration, and development of oil and gas properties. BowLeven holds equity interests in offshore and onshore exploration acreage in Cameroon and …
  • National Cancer Center Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary National Cancer Center Hospital (NCC) is a healthcare service provider that offers cancer care services. The hospital provides cancer diagnosis and treatment services. It provides services such as examination, treatment, patient care services and co-medical support. NCC provides diagnosis an …
  • EKF Diagnostics Holdings Plc (EKF)-医療機器分野:企業M&A・提携分析
    Summary EKF Diagnostics Holdings Plc (EKF Diagnostics) is a medical device company which designs, develops, manufactures, and commercializes chemical reagents, and analyzers for the measurement of glucose, lactate, hematocrit, hemoglobin, and glycated hemoglobin. The company’s product portfolio comp …
  • CPFL Energia SA (CPFE3):電力:M&Aディール及び事業提携情報
    Summary CPFL Energia S.A. (CPFL), formerly Companhia Paulista de Forca e Luz, is an electric utility, which carries out regulated and non-regulated electricity business. The company through its subsidiaries generates, transmits, distributes and commercializes electricity. It generates electricity us …
  • Valero Energy Corp (VLO):石油・ガス:M&Aディール及び事業提携情報
    Summary Valero Energy Corp (Valero) is a downstream company that manufactures and markets transportation fuels and petrochemical products. The company’s assets include petroleum refineries, ethanol plants and renewable diesel production from a joint venture. Its refineries produce gasoline, diesel, …
  • juwi AG:企業の戦略的SWOT分析
    juwi AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Steelcase Inc.
    Steelcase Inc. - Strategy, SWOT and Corporate Finance Report Summary Steelcase Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Damco International B.V.:企業の戦略・SWOT・財務分析
    Damco International B.V. - Strategy, SWOT and Corporate Finance Report Summary Damco International B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • 3-V Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary 3-V Biosciences Inc (3-V Biosciences) is a clinical-stage pharmaceutical company that develops novel therapeutics in metabolic diseases. The company offers TVB-2640, a fatty acid synthase inhibitor used for the treatment of solid tumors, including non-small cell lung cancer (NSCLC), breast c …
  • Essar Power Limited:電力:M&Aディール及び事業提携情報
    Summary Essar Power Limited (Essar Power) a subsidiary of Essar Energy Limited, is an electric utility. It produces electricity and thermal energy. The company generates power from naphtha, high-speed diesel, coal, natural gasoline liquid, and natural gas sources. Essar Power owns and operates co-ge …
  • Capitol Federal Financial, Inc:企業の戦略・SWOT・財務情報
    Capitol Federal Financial, Inc - Strategy, SWOT and Corporate Finance Report Summary Capitol Federal Financial, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Constellation Brands Inc (STZ):企業の財務・戦略的SWOT分析
    Constellation Brands Inc (STZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Ahli United Bank BSc:企業の戦略・SWOT・財務分析
    Ahli United Bank BSc - Strategy, SWOT and Corporate Finance Report Summary Ahli United Bank BSc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆